妊娠哺乳相关骨质疏松症发病率及相关影响因素的调查研究
Investigation on the Incidence of Osteoporosis Associated with Pregnancy and Lactation and Its Related Influencing Factors
DOI: 10.12677/ACM.2021.116405, PDF,   
作者: 易少华*, 乔会峰, 吴宏梓, 凯瑟尔, 刘芮君, 张 艳, 肖 岚, 巴雪峰#:新疆克拉玛依市中心医院骨科中心,新疆 克拉玛依;王 慧:新疆克拉玛依市中心医院妇产科,新疆 克拉玛依;张学平:新疆克拉玛依市中心医院核医学科,新疆 克拉玛依
关键词: 妊娠哺乳相关骨质疏松症(PLO)发病率影响因素防治Pregnancy and Lactation Associated Osteoporosis (PLO) Incidence of Disease Influencing Factors The Prevention and Treatment
摘要: 目的:横断面调查妊娠哺乳相关骨质疏松症(pregnancy and lactation-associated osteoporosis, PLO)发病率及相关影响因素,为产妇骨骼健康提供指导。方法:对656例新疆克拉玛依市中心医院自愿参加X线吸收检测法(dual energy X-ray absorptiometry, DXA)骨密度测量的产妇于产后6个月进行腰椎、髋部的骨密度测量,采用自行设计的调查问卷进行PLO生活方式的调查,同时对骨量异常患者进行骨转换指标、生化指标检测。结果:产后6月骨质疏松症(T值 ≤ −2.5)患病率:8/656 = 1.21%、骨量减少(−2.5 < T值 < −1.0)患病率:72/656 = 10.97%,PLO (Z值 < −2.0) 11/656 = 1.67%。按T值标准,PLO组:1) 基础病因素:骨量减少患者:24例,骨质疏松8例;2) 二胎:骨质疏松6例,骨量减少8例;3) 所有骨量异常患者均钙、维生素D摄入不足且均运动小于30分钟/天;4) 日照时间小于30分钟/天者:骨质疏松4例,骨量减少30例;5) 长期喝茶9例均为骨量减少患者;6) 产后6个月月经未复潮者:骨质疏松8例,骨量减少30例;7) 骨转换指标:血清PINP、β-CTX、甲状旁腺激素、碱性磷酸酶除甲状腺功能亢进患者外均在正常范围;25-羟VitD平均13.2 ng/ml;8) 疼痛评分(VAS) 1.24 ± 0.95分,疼痛、抽搐(月) 3.2月;9) 母乳喂养率100%且≥6个月。正常骨量组:1) 基础病因素:2例(慢性胃炎2例);2) 二胎2人;3) 钙、维生素D摄入不足56例,运动小于30分钟/天64例;4) 日照时间小于30分钟/天者14例;5) 不良健康习惯者0例;6) 6个月月经未复潮者0例;7) 骨转换指标:未测;25-羟VitD未测;8) 疼痛评分(VAS) 0.24 ± 0.36分,无抽搐;9) 母乳喂养率30.1%,平均时间3.12月。结论:PLO发病率较低且伴随骨痛;PLO危险因素为基础疾病、不良饮食习惯、哺乳时间6个月、钙和维生素D摄入不足、日照时间不足及运动不足,混合危险因素可能存在叠加促进作用;以上结论需要大样本继续验证。
Abstract: Objective: To investigate the incidence of pregnancy and lactation-associated osteoporosis (PLO) and its related factors in a cross-sectional manner, and to provide guidance for bone health of parturients. Methods: The BMD of lumbar spine and hip of 656 parturients who volunteered to take part in Dual Energy X-Ray Absorptiometry (DXA) measurement in Karamay Central Hospital of Xinjiang at 6 months postpartum were measured. A self-designed questionnaire was used to investigate PLO lifestyle. Meanwhile, bone conversion indexes and biochemical indexes were detected in patients with abnormal bone mass. Results: The prevalence of osteoporosis (T value ≤ −2.5) at 6 months postpartum was 8/656 = 1.21%, the prevalence of osteopenia (−2.5 < T-value < −1.0) was 72/656 = 10.97% (T value), PLO (Z value) 11/656 = 1.67%. According to the T-value standard, PLO group: 1) Basic disease factors: osteopenia: 24 cases, 8 cases of osteoporosis; 2) Second birth: osteoporosis in 6 cases, bone loss in 8 cases; 3) All patients with abnormal bone mass had insufficient calcium and vitamin D intake and exercised less than 30 minutes per day; 4) Patients with sunshine time less than 30 minutes per day had osteoporosis in 4 cases and bone loss in 30 cases; 5) Drinking tea for a long time in 9 patients with osteopenia; 6) 6 months of menstruation did not return to the tide: osteoporosis in 8 cases, bone loss in 30 cases; 7) Bone turnover indexes: serum PINP, β-CTX, parathyroid hormone and alkaline phosphatase were all in the normal range except for patients with hyperthyroidism; the average 25-hydroxy VitD was 13.2 ng/mL; 8) Pain score (VAS) 1.24 ± 0.95, pain and convulsions (months) 3.2 months; 9) Breastfeeding rate 100%, ≥6 months. Normal bone mass group: 1) basic disease factors: 2 cases (chronic gastritis 2 cases); 2) there were 2 children in the second child; 3) there were 56 patients with insufficient calcium and vitamin D intake and 64 patients with exercise less than 30 minutes per day; 4) the sunshine time was less than 30 minutes per day in 14 cases; 5) 0 cases with bad health habits; 6) 6 months without menstrual regurgitation in 0 cases; 7) bone turnover index: unmeasured; 25-hydroxy VitD was not measured; 8) pain score (VAS) 0.24 ± 0.36, no convulsions; 9) the rate of breastfeeding was 30.1%, with an average duration of 3.12 months. Conclusion: The incidence of PLO is low and accompanied by bone pain. PLO risk factors are based on diseases, poor dietary habits, breastfeeding time of 6 months, insufficient calcium and vitamin D intake, insufficient sunshine time and insufficient exercise, and mixed risk factors may have a superimposed promoting effect. The above conclusions need to be further verified with large samples.
文章引用:易少华, 乔会峰, 吴宏梓, 凯瑟尔, 刘芮君, 王慧, 张艳, 肖岚, 张学平, 巴雪峰. 妊娠哺乳相关骨质疏松症发病率及相关影响因素的调查研究[J]. 临床医学进展, 2021, 11(6): 2793-2800. https://doi.org/10.12677/ACM.2021.116405

参考文献

[1] Olausson, H., Goldberg, G.R., Laskey, M.A., et al. (2012) Calcium Economy in Human Pregnancy and Lactation. Nutrition Research Reviews, 25, 40-67. [Google Scholar] [CrossRef
[2] Schoenmakers, I., Jarjou, L.M., Goldberg, G.R., et al. (2013) Acute Response to Oral Calcium Loading in Pregnant and Lactating Women with a Low Calcium Intake: A Pilot Study. Osteoporosis International, 24, 2301-2308. [Google Scholar] [CrossRef] [PubMed]
[3] Saint, L., Maggiore, P. and Hartmann, P.E. (2007) Yield and Nutrient Content of Milk in Eight Women Breast-Feeding Twins and One Woman Breastfeeding Triplets. British Journal of Nutrition, 56, 49-58. [Google Scholar] [CrossRef
[4] 许琳, 裴育. 妊娠哺乳相关性骨质疏松症诊治[J]. 中华骨质疏松和骨矿盐疾病杂志, 2019, 11(12): 631-637.
[5] 中国老年学学会骨质疏松委员会. 中国人骨质疏松症诊断标准专家共识(第三稿2014 版) [J]. 中国骨质疏松杂志, 2014, 9(20): 1007-1010.
[6] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017) [J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-443.
[7] 张丽伟. 1249例孕妇骨密度测定结果分析[J]. 沈阳医学院学报, 2017, 19(1): 24-29.
[8] 张海燕, 任钧, 张高东. 产后妇女骨密度变化及影响因素研究[J]. 重庆医学, 2011, 25(40): 2539-2540.
[9] 欧阳穗. 妊娠前、妊娠期及哺乳期妇女1173例骨密度检测分析[J]. 实用医学杂志, 2012, 28(14): 2363-2364.
[10] Ferrari, S., Bianchi, M.L., Eisman, J.A., et al. (2012) Osteoporosis in Young Adults: Pathophysiology, Diagnosis, and Management. Osteoporosis International, 23, 2735-2748. [Google Scholar] [CrossRef] [PubMed]
[11] 曹民治, 耿春梅, 阿茹娜, 等. 婴儿喂养方式与产妇体质及产后月经复潮相关性研究[J]. 中国现代医学杂志, 2016, 26(24): 119-123.
[12] 中华医学会儿科学分会儿童保健学组. 母乳喂养促进策略指南(2018版) [J]. 中华儿科杂志, 2018, 10(4): 261-266.
[13] American College of Obstetricians and Gynecologists' Committee on Obstetric Practice (2016) Committee Opinion No. 656: Guidelines for Diagnostic for Diagnostic Imaging during Pregnancy and Lactation. Obstetrics & Gynecology, 127, e75-e80. [Google Scholar] [CrossRef
[14] 欧阳振波, 尹倩, 全松, 张秋实. 美国妇产科医师学会关于妊娠期及哺乳期影像学检测安全性指南的解读(2016版) [J]. 现代妇产科进展杂志, 2016, 25(9): 712-714.